ezetimibe has been researched along with phosphocreatine in 1 studies
Studies (ezetimibe) | Trials (ezetimibe) | Recent Studies (post-2010) (ezetimibe) | Studies (phosphocreatine) | Trials (phosphocreatine) | Recent Studies (post-2010) (phosphocreatine) |
---|---|---|---|---|---|
2,484 | 563 | 1,465 | 7,475 | 329 | 575 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anderson, JD; Berr, SS; Christopher, JM; Dimaria, JM; Epstein, FH; Hagspiel, KD; Harthun, NL; Hunter, JR; Kramer, CM; Meyer, CH; Wang, H; Weltman, AL; West, AM | 1 |
1 trial(s) available for ezetimibe and phosphocreatine
Article | Year |
---|---|
Low-density lipoprotein lowering does not improve calf muscle perfusion, energetics, or exercise performance in peripheral arterial disease.
Topics: Aged; Anticholesteremic Agents; Azetidines; Cholesterol, LDL; Energy Metabolism; Exercise Test; Exercise Tolerance; Ezetimibe; Female; Humans; Leg; Magnetic Resonance Angiography; Magnetic Resonance Spectroscopy; Male; Middle Aged; Muscle, Skeletal; Peripheral Arterial Disease; Phosphocreatine; Simvastatin | 2011 |